 |
Funding Opportunites - Research
Further details regarding this announcement can be found at:
http://static1.squarespace.com/static/55a90da3e4b0fd7cb1a224da/t/5734a6f4f8baf3a1107cb3dd/1463068408023/BioCanRxClinical
|
|
Sponsor/Award: |
NETWORK CENTRES OF EXCELLENCE - BIOCANRX | CLINICAL TRIAL PROGRAM - 2016 FALL COMPETITION |
|
|
Grant Amount: |
|
|
Deadline: |
Dean's: Contact your Faculty Research Office for deadline details.
Internal: Nov 02, 2016
Sponsor's: Nov 09, 2016
|
|
|
Subject Areas: |
|
|
Description: |
Founded in 2015, BioCanRx (Biotherapeutics for Cancer Treatment) is a not-for-profit organization with a mission to improve outcomes for cancer patients by accelerating the development of cost-effective and curative biotherapies. BioCanRx supports biotherapeutic development research through four research programs and a number of core facilities that are accessible to all members of the BioCanRx network. This program will provide financial support for the clinical evaluation in Canada of novel biotherapeutic products and platforms that have been substantially developed in Canada. The program is focused on clinical trials using biotherapeutics, including but not limited to: oncolytic viruses, immune cell therapies, and therapeutic antibodies, either as mono-therapies or in combination. The required deliverables include clinical data required to evaluate the case for advancing the therapeutic into later-stage clinical development. |
|
|
Application Details: |
BioCanRx uses a rolling open call that starts with a letter-of-intent stage and has submission deadlines that are structured around the meeting dates of our Research Management Committee. Successful LOI's will be invited to submit a full application in line with the scheduled meeting dates.The completed Letter of Intent (LOI) or full application must be delivered by email to applications@biocanrx.com and must be received by 11:59 pm ET, on the deadline in advance of the next scheduled RMC meeting (see Apply for funding on the BioCanRx website). |
|
NOTE: All Letters of Intent and Full Applications must be processed through Research Development & Services for institutional approval. Requests for Institutional approvals should be received no less than 3 days prior to the posted Sponsor deadline. A ROLA Proposal (bearing applicant, Chair and Dean electronic approvals) is required for each submission. |
|
Western Contacts: |
Moxey,Laura
Kilianski,Louise
Hancock,Jennifer Anne
|
|
|
Sponsor Contacts: |
DR. KELLEY PARATO: KEPARATO@BIOCANRX.COM
501 Smyth Road, Box 611
Ottawa, Ontario, Canada
|